Annual Cash & Cash Equivalents
$2.16 B
-$562.30 M-20.65%
30 September 2024
Summary:
Hologic annual cash & cash equivalents is currently $2.16 billion, with the most recent change of -$562.30 million (-20.65%) on 30 September 2024. During the last 3 years, it has risen by +$989.90 million (+84.59%). HOLX annual cash & cash equivalents is now -20.65% below its all-time high of $2.72 billion, reached on 30 September 2023.HOLX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$2.16 B
-$278.90 M-11.43%
30 September 2024
Summary:
Hologic quarterly cash and cash equivalents is currently $2.16 billion, with the most recent change of -$278.90 million (-11.43%) on 30 September 2024. Over the past year, it has dropped by -$562.30 million (-20.65%). HOLX quarterly cash and cash equivalents is now -21.87% below its all-time high of $2.77 billion, reached on 01 June 2023.HOLX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HOLX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.6% | -20.6% |
| 3 y3 years | +84.6% | +84.6% |
| 5 y5 years | +259.0% | +259.0% |
HOLX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -20.6% | +84.6% | -21.9% | +84.6% |
| 5 y | 5 years | -20.6% | +259.0% | -21.9% | +482.6% |
| alltime | all time | -20.6% | >+9999.0% | -21.9% | >+9999.0% |
Hologic Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | $2.16 B(-20.7%) | $2.16 B(-11.4%) |
| June 2024 | - | $2.44 B(+11.9%) |
| Mar 2024 | - | $2.18 B(+12.8%) |
| Dec 2023 | - | $1.93 B(-29.0%) |
| Sept 2023 | $2.72 B(+16.4%) | $2.72 B(-1.5%) |
| June 2023 | - | $2.77 B(+7.1%) |
| Mar 2023 | - | $2.58 B(+5.8%) |
| Dec 2022 | - | $2.44 B(+4.4%) |
| Sept 2022 | $2.34 B(+99.9%) | $2.34 B(-1.5%) |
| June 2022 | - | $2.38 B(+3.7%) |
| Mar 2022 | - | $2.29 B(+61.2%) |
| Dec 2021 | - | $1.42 B(+21.4%) |
| Sept 2021 | $1.17 B(+66.9%) | $1.17 B(+41.4%) |
| June 2021 | - | $827.60 M(+1.4%) |
| Mar 2021 | - | $816.40 M(-6.0%) |
| Dec 2020 | - | $868.70 M(+23.9%) |
| Sept 2020 | $701.00 M(+16.5%) | $701.00 M(-5.8%) |
| June 2020 | - | $744.20 M(-7.0%) |
| Mar 2020 | - | $799.80 M(+115.7%) |
| Dec 2019 | - | $370.80 M(-38.4%) |
| Sept 2019 | $601.80 M(-9.7%) | $601.80 M(+40.6%) |
| June 2019 | - | $427.90 M(+6.7%) |
| Mar 2019 | - | $401.00 M(+28.9%) |
| Dec 2018 | - | $311.10 M(-53.3%) |
| Sept 2018 | $666.70 M(+23.3%) | $666.70 M(+15.9%) |
| June 2018 | - | $575.40 M(-6.3%) |
| Mar 2018 | - | $614.20 M(-7.6%) |
| Dec 2017 | - | $664.40 M(+22.9%) |
| Sept 2017 | $540.60 M(-1.4%) | $540.60 M(-8.1%) |
| June 2017 | - | $588.40 M(-48.1%) |
| Mar 2017 | - | $1.13 B(+75.6%) |
| Dec 2016 | - | $646.00 M(+17.8%) |
| Sept 2016 | $548.40 M(+11.6%) | $548.40 M(+24.2%) |
| June 2016 | - | $441.50 M(+39.6%) |
| Mar 2016 | - | $316.30 M(-51.4%) |
| Dec 2015 | - | $650.30 M(+32.4%) |
| Sept 2015 | $491.30 M(-33.3%) | $491.30 M(-44.5%) |
| June 2015 | - | $885.00 M(+32.0%) |
| Mar 2015 | - | $670.50 M(+23.3%) |
| Dec 2014 | - | $544.00 M(-26.1%) |
| Sept 2014 | $736.10 M(-10.5%) | $736.10 M(+16.4%) |
| June 2014 | - | $632.50 M(+30.5%) |
| Mar 2014 | - | $484.52 M(+9.5%) |
| Dec 2013 | - | $442.49 M(-46.2%) |
| Sept 2013 | $822.50 M(+46.8%) | $822.50 M(-14.2%) |
| June 2013 | - | $958.44 M(+28.7%) |
| Mar 2013 | - | $745.00 M(+3.7%) |
| Dec 2012 | - | $718.47 M(+28.2%) |
| Sept 2012 | $560.43 M(-21.3%) | $560.43 M(-38.1%) |
| June 2012 | - | $905.08 M(+5.9%) |
| Mar 2012 | - | $854.56 M(+7.8%) |
| Dec 2011 | - | $793.08 M(+11.3%) |
| Sept 2011 | $712.33 M(+38.1%) | $712.33 M(+16.1%) |
| June 2011 | - | $613.80 M(+7.1%) |
| Mar 2011 | - | $572.92 M(-5.8%) |
| Dec 2010 | - | $608.04 M(+17.9%) |
| Sept 2010 | $515.63 M(+75.9%) | $515.63 M(+4.9%) |
| June 2010 | - | $491.37 M(+13.9%) |
| Mar 2010 | - | $431.31 M(+25.0%) |
| Dec 2009 | - | $345.04 M(+17.7%) |
| Sept 2009 | $293.19 M(+206.5%) | $293.19 M(+20.3%) |
| June 2009 | - | $243.72 M(+12.2%) |
| Mar 2009 | - | $217.23 M(+26.7%) |
| Dec 2008 | - | $171.48 M(+79.3%) |
| Sept 2008 | $95.66 M | $95.66 M(-20.2%) |
| June 2008 | - | $119.86 M(+22.6%) |
| Mar 2008 | - | $97.80 M(-36.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | - | $154.66 M(+54.0%) |
| Sept 2007 | $100.40 M(+235.5%) | $100.40 M(+7.0%) |
| June 2007 | - | $93.80 M(+72.1%) |
| Mar 2007 | - | $54.50 M(+46.1%) |
| Dec 2006 | - | $37.31 M(+24.7%) |
| Sept 2006 | $29.92 M(-73.8%) | $29.92 M(-72.8%) |
| June 2006 | - | $110.14 M(+1.7%) |
| Mar 2006 | - | $108.28 M(+14.6%) |
| Dec 2005 | - | $94.51 M(-17.1%) |
| Sept 2005 | $113.99 M(+66.8%) | $113.99 M(+11.5%) |
| June 2005 | - | $102.25 M(+6.9%) |
| Mar 2005 | - | $95.69 M(+31.6%) |
| Dec 2004 | - | $72.70 M(+6.4%) |
| Sept 2004 | $68.33 M(+51.3%) | $68.33 M(+20.0%) |
| June 2004 | - | $56.94 M(+1.4%) |
| Mar 2004 | - | $56.13 M(+24.7%) |
| Dec 2003 | - | $45.02 M(-0.4%) |
| Sept 2003 | $45.18 M(-1.4%) | $45.18 M(+13.3%) |
| June 2003 | - | $39.87 M(+26.9%) |
| Mar 2003 | - | $31.42 M(-27.3%) |
| Dec 2002 | - | $43.21 M(-5.7%) |
| Sept 2002 | $45.84 M(+259.4%) | $45.84 M(+43.5%) |
| June 2002 | - | $31.94 M(+21.8%) |
| Mar 2002 | - | $26.23 M(-14.3%) |
| Dec 2001 | - | $30.60 M(+139.9%) |
| Sept 2001 | $12.75 M(-44.0%) | $12.75 M(+7.1%) |
| June 2001 | - | $11.91 M(-26.3%) |
| Mar 2001 | - | $16.17 M(-27.7%) |
| Dec 2000 | - | $22.36 M(-1.8%) |
| Sept 2000 | $22.78 M(-37.6%) | $22.78 M(-33.2%) |
| June 2000 | - | $34.10 M(-7.1%) |
| Mar 2000 | - | $36.72 M(+1.7%) |
| Dec 1999 | - | $36.10 M(-1.1%) |
| Sept 1999 | $36.50 M(-24.6%) | $36.50 M(-4.9%) |
| June 1999 | - | $38.40 M(+4.9%) |
| Mar 1999 | - | $36.60 M(-24.4%) |
| Dec 1998 | - | $48.40 M(0.0%) |
| Sept 1998 | $48.40 M(+72.2%) | $48.40 M(+5.4%) |
| June 1998 | - | $45.90 M(+5.0%) |
| Mar 1998 | - | $43.70 M(-3.3%) |
| Dec 1997 | - | $45.20 M(+60.9%) |
| Sept 1997 | $28.10 M(-2.4%) | $28.10 M(-15.6%) |
| June 1997 | - | $33.30 M(-21.8%) |
| Mar 1997 | - | $42.60 M(+28.3%) |
| Dec 1996 | - | $33.20 M(+15.3%) |
| Sept 1996 | $28.80 M(+289.2%) | $28.80 M(-9.4%) |
| June 1996 | - | $31.80 M(-45.1%) |
| Mar 1996 | - | $57.90 M(+606.1%) |
| Dec 1995 | - | $8.20 M(+10.8%) |
| Sept 1995 | $7.40 M(+25.4%) | $7.40 M(+10.4%) |
| June 1995 | - | $6.70 M(-31.6%) |
| Mar 1995 | - | $9.80 M(+18.1%) |
| Dec 1994 | - | $8.30 M(+40.7%) |
| Sept 1994 | $5.90 M(-11.9%) | $5.90 M(+68.6%) |
| June 1994 | - | $3.50 M(-25.5%) |
| Mar 1994 | - | $4.70 M(+6.8%) |
| Dec 1993 | - | $4.40 M(-34.3%) |
| Sept 1993 | $6.70 M(+179.2%) | $6.70 M(+6.3%) |
| June 1993 | - | $6.30 M(+80.0%) |
| Mar 1993 | - | $3.50 M(+45.8%) |
| Sept 1992 | $2.40 M(-73.3%) | $2.40 M(-41.5%) |
| June 1992 | - | $4.10 M(+105.0%) |
| Mar 1992 | - | $2.00 M(-58.3%) |
| Dec 1991 | - | $4.80 M(-46.7%) |
| Sept 1991 | $9.00 M(-32.8%) | $9.00 M(-32.8%) |
| Sept 1990 | $13.40 M(+570.0%) | $13.40 M(+38.1%) |
| Mar 1990 | - | $9.70 M(+385.0%) |
| Sept 1989 | $2.00 M | $2.00 M |
FAQ
- What is Hologic annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Hologic?
- What is Hologic annual cash & cash equivalents year-on-year change?
- What is Hologic quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Hologic?
- What is Hologic quarterly cash and cash equivalents year-on-year change?
What is Hologic annual cash & cash equivalents?
The current annual cash & cash equivalents of HOLX is $2.16 B
What is the all time high annual cash & cash equivalents for Hologic?
Hologic all-time high annual cash & cash equivalents is $2.72 B
What is Hologic annual cash & cash equivalents year-on-year change?
Over the past year, HOLX annual cash & cash equivalents has changed by -$562.30 M (-20.65%)
What is Hologic quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of HOLX is $2.16 B
What is the all time high quarterly cash and cash equivalents for Hologic?
Hologic all-time high quarterly cash and cash equivalents is $2.77 B
What is Hologic quarterly cash and cash equivalents year-on-year change?
Over the past year, HOLX quarterly cash and cash equivalents has changed by -$562.30 M (-20.65%)